Wolters Kluwer Health Completes Divestment of ProVation

Wolters Kluwer Health announces today that it has completed the divestment of ProVationMedical to Clearlake Capital Group, L.P., as originally announced on January 11, 2018.<br /> <br /><br />About Wolters Kluwer<br />Wolters Kluwer N.V. (AEX: WKL) is a global leader in information, software solutions, and services for professionals in the health, tax and accounting,...

Wolters Kluwer Health announces today that it has completed the divestment of ProVationMedical to Clearlake Capital Group, L.P., as originally announced on January 11, 2018.

 

 

About Wolters Kluwer

Wolters Kluwer N.V. (AEX: WKL) is a global leader in information, software solutions, and services for professionals in the health, tax and accounting, risk and compliance, finance and legal sectors. We help our customers make critical decisions every day by providing expert solutions that combine deep domain knowledge with specialized technology and services.

Wolters Kluwer reported 2017 annual revenues of €4.4 billion. The company, headquartered in Alphen aan den Rijn, the Netherlands, serves customers in over 180 countries, maintains operations in over 40 countries, and employs 19,000 people worldwide.

Wolters Kluwer shares are listed on Euronext Amsterdam (WKL) and are included in the AEX and Euronext 100 indices. Wolters Kluwer has a sponsored Level 1 American Depositary Receipt program. The ADRs are traded on the over-the-counter market in the U.S. (WTKWY).

Source: www.wolterskluwerhealth.com